Frailty in Older Adults with Prostate Cancer

IF 9.3 1区医学 Q1 ONCOLOGY European urology oncology Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI:10.1016/j.euo.2024.11.007

Neha Pathak , Efthymios Papadopoulos , Vikaash Kumar , Shabbir Alibhai

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

老年前列腺癌患者的虚弱。

患有前列腺癌各个阶段的老年人都容易变得虚弱。这些患者应进行虚弱评估，并由多学科团队进行管理。生活方式的措施和癌症相关治疗的量身定制，以病人的健康水平可以帮助减轻虚弱的不利影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format

期刊最新文献

Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival. Re: Blackmur JP, Rossi SH, Kuusk T, et al. Prediction Models for Shared Decision-making by Patients with Localised Renal Masses: A Systematic Review and a Survey of Patient and Clinician Priorities. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.02.008: Outcome Prediction in Localised Renal Cancer: We Need to Do Better. Methodological Considerations on Causal Interpretability of the IRRADIaTE Registry. Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks. DaBlaCa-13 Study: Five-year Follow-up from the Randomized Controlled Trial of Chemoresection with Intravesical Mitomycin C in Recurrent Ta Non-muscle-invasive Bladder Cancer.